MedTrace Logo

Combined Letrozole and Clomid in Women With Infertility and PCOS

NCT02802865 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2019-09-27

Study results available
· View outcomes & findings →

Summary

This study evaluates the addition of clomid to letrozole for the treatment of infertility in women with polycystic ovary syndrome. Half of the participants will receive letrozole and clomid in combination, while the other half will receive letrozole alone.

Conditions

Interventions

DRUG

Clomiphene

DRUG

Letrozole

Sponsors & Collaborators

  • Rachel Mejia

    lead OTHER

Principal Investigators

  • Rachel Mejia, DO · University of Iowa Hosptials & Clinics

  • Brad Van Voorhis, MD · University of Iowa Hospitals & Clinics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-05-31
Completion
2019-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02802865 on ClinicalTrials.gov